Percipio Biosciences recently purchased OXIS International’s research product line. Percipio develops technologies and products to research, diagnose, treat and prevent diseases of oxidative stress associated with damage from free radical and reactive oxygen species. Percipio is the premier source for research products targeting biomarkers of oxidative stress, with a comprehensive range of products for the test of endogenous antioxidants (e.g. SOD, Catalase, GSH and GSH related enzymes).

• Assays
  • Bioxytech assay kits to simplify the test of Oxidative, Antioxidant, Nitrosative and Inflammatory Biomarkers in diseases including Cancer, Diabetes, and Atherosclerosis etc.
  • for biomarkers of inflammation measurement related to cardiovascular disease, including Troponin I, Myoglobin, High Sensitivity C-Reactive Protein etc.
  • for lipid, protein and DNA determinants of oxidative mediated damage
• Antibodies and Enzymes - allowing IHC, Western Blotting and HPLC analysis of key biomarkers
• Antioxidants
• Controls
• Special chemicals